(GEM Imaging S.A.) is a Spanish company formed in 2003 with the initiative of the Corpuscular Physics Institute (CSIC) and the University of Valencia.

OncoVision work in Molecular Vision applied to Health Sciences focusing in cancer diagnosis and treatment and advanced research in neurology, oncology and cardiology.

They are a company focused on Molecular Vision, which creates, develops and markets new medical technologies, global innovations with relevant clinical and economic advantages, often representing a breakthrough in current standards of diagnosis and treatment.